Commonwealth Equity Services
PRME icon

Commonwealth Equity Services’s Prime Medicine PRME Stock Holding History

Commonwealth Equity Services’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$57.2K Sell
16,437
-17,962
-52% -$68.4K ﹤0.01% 4190
2025
Q4 		$119K Sell
34,399
-28,769
-46% -$128K ﹤0.01% 4085
2025
Q3 		$350K Buy
63,168
+48,226
+323% +$196K ﹤0.01% 3501
2025
Q2 		$37K Buy
+14,942
New +$23K ﹤0.01% 4188

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Commonwealth Equity Services's PRME Position: Q1 2026 in Review

Commonwealth Equity Services reduced its Prime Medicine (PRME) stake by 52% in Q1 2026, selling an estimated $68.4K and leaving 16,437 shares worth $57.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4190.

Commonwealth Equity Services first reported a position in PRME in Q2 2025 and has held it in 4 quarters since. The position peaked at $350K in Q3 2025. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • Commonwealth Equity Services held 16,437 shares of Prime Medicine worth $57.2K as of Q1 2026.
  • Commonwealth Equity Services sold 17,962 Prime Medicine shares in Q1 2026, an estimated $68.4K.
  • Prime Medicine made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q1 2026, its #4190 holding.
  • Commonwealth Equity Services first reported a position in Prime Medicine in Q2 2025 and has held it in 4 quarters since.
  • Commonwealth Equity Services's Prime Medicine position peaked at $350K in Q3 2025.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.